Intrinsiqs

Is Gain Therapeutics, Inc. overvalued?

Gain Therapeutics, Inc. (GANX) — key valuation metrics and fundamentals.

No verdict
Price
$1.77
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$75.5M
Dividend yield
0.0%
Return on equity
-161.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares GANX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.